Reports
Liechtenstein's VP Bank's AuM Rises, Group Net Income Drops

The private bank's cost/income ratio widened quite sharply in 2018.
Liechtenstein-based VP
Bank announced that it had logged net new money of SFr3.2
billion ($3.2 billion) for 2018, lifting assets under management
to SFr41.5 billion, up by 2.8 per cent over 2017’s level, it said
yesterday but it announced that group net income slid by 16.8 per
cent to SFr54.7 million.
The bank said it is not proposing to change its dividend when it
holds its annual meeting on 26 April.
The cost/income ratio rose to 75.8 per cent, widening from 64.2
per cent.
On the earnings side, interest income (+ 6.3 per cent) as well as
trading activities (+9.4 per cent) performed “particularly well”,
VP Bank said. Commission business and services rose only slightly
(+ 0.3 per cent).
Operating expenses rose to SFR232.3 million from SFr229.8 million
in 2017.
VP Bank said that financial assets produced a loss of SFr1.6
million, which contrasts with the profit of SFr19.2 million
recorded in 2017. The SFr20.9 million cut was caused by
non-realisable valuation losses on financial instruments.
The tier 1 ratio amounted to 20.9 per cent and the leverage ratio
to 7.3 per cent.
“Even though the past financial year was difficult due to the
persistently low interest rate environment and weak performance
on international financial markets: in operating terms VP Bank
performed well, particularly on the earnings side,” the lender
said.
“The renewed rise in net new assets beat expectations and
underscores the effectiveness of our growth strategy. We are
confident that we will be able to generate additional income from
our numerous investments over the coming years,” Dr Urs Monstein,
interim chief executive of VP Bank Group, said.
Last year the bank changed its management structure: On 1 March,
Dr Felix Brill joined VP Bank as the new chief investment officer
and head of the “Investment Solutions” unit formed the previous
year. With Brill, the number of members of the group executive
management rose to a total of six.
Dr Urs Monstein joined the group executive management on 1 May in
the capacity of chief operating officer. After the group
announced the departure of Alfred W Moeckli as CEO, Urs Monstein
was also made interim head of group executive management.